Flotetuzumab
Flotetuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Flotetuzumab is under investigation in clinical trial NCT02152956 (Safety Study of MGD006 in Relapsed/Refractory Acute Myeloid Leukemia (AML) or Intermediate-2/High Risk MDS).
| Trade Name | Flotetuzumab |
| Generic | Flotetuzumab |
| Flotetuzumab Other Names | Flotetuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Flotetuzumab
